These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid. Ninane G; Joly J; Kraytman M; Piot P Lancet; 1978 Jul; 2(8083):257. PubMed ID: 79045 [No Abstract] [Full Text] [Related]
43. [Clinical study of respiratory infection due to Branhamella catarrhalis using transtracheal aspiration]. Konishi M; Sawaki M; Mikasa K; Takeuchi S; Maeda K; Hamada K; Kunimatsu M; Narita N Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):886-91. PubMed ID: 1630054 [TBL] [Abstract][Full Text] [Related]
47. Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis. Percival A; Corkill JE; Rowlands J; Sykes RB Lancet; 1977 Dec; 2(8049):1175. PubMed ID: 73082 [No Abstract] [Full Text] [Related]
48. Branhamella catarrhalis as a human pathogen and a possible hospital infectant. Brzin B Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 249(4):483-6. PubMed ID: 7198350 [TBL] [Abstract][Full Text] [Related]
49. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. Ninane G; Joly J; Kraytman M Br Med J; 1978 Feb; 1(6108):276-8. PubMed ID: 620304 [TBL] [Abstract][Full Text] [Related]
50. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics]. Texier-Maugein J; Escoubas J; Fouche J; Mormede M Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431 [TBL] [Abstract][Full Text] [Related]
51. Bacteremia caused by a beta-lactamase producing strain of Branhamella catarrhalis. A case report. Christensen JJ; Bruun B Acta Pathol Microbiol Immunol Scand B; 1985 Aug; 93(4):273-5. PubMed ID: 3876684 [TBL] [Abstract][Full Text] [Related]
52. Moraxella catarrhalis, a human respiratory tract pathogen. Murphy TF; Parameswaran GI Clin Infect Dis; 2009 Jul; 49(1):124-31. PubMed ID: 19480579 [TBL] [Abstract][Full Text] [Related]
53. Prevalence of beta-lactamase-producing bacteria in chronic suppurative otitis media. Brook I Am J Dis Child; 1985 Mar; 139(3):280-3. PubMed ID: 3872063 [TBL] [Abstract][Full Text] [Related]
54. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections]. Bourgeois F; Lambert-Zechovsky N; Bingen E Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636 [TBL] [Abstract][Full Text] [Related]
55. Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report. Shurin PA; Van Hare GF Drugs; 1986; 31 Suppl 3():122-4. PubMed ID: 3488191 [TBL] [Abstract][Full Text] [Related]
56. [Branhamella catarrhalis--a respiratory tract pathogen with the ability to produce beta-lactamases]. Malmvall BE Lakartidningen; 1984 Oct; 81(43):3931-2. PubMed ID: 6334796 [No Abstract] [Full Text] [Related]
57. Lack of immunoglobulin A1 protease production by Branhamella catarrhalis. McLeod DT; Croughan MJ; Ahmad F; Brettle RP; Calder MA Infect Immun; 1986 May; 52(2):631-2. PubMed ID: 3516884 [TBL] [Abstract][Full Text] [Related]
58. Infections of the upper respiratory tract, head, and neck. The role of anaerobic bacteria. Brook I Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):37-48. PubMed ID: 19667548 [TBL] [Abstract][Full Text] [Related]
59. Hospital-acquired bronchopulmonary infection in premature infants due to Branhamella catarrhalis. Haddad J; Le Faou A; Simeoni U; Messer J J Hosp Infect; 1986 May; 7(3):301-2. PubMed ID: 2873180 [No Abstract] [Full Text] [Related]